Sumbul Beg, MD

Endo in a Bite

Health EN ↓ 73 episodes

This podcast from EZ Endo Prep delivers concise, high yield endocrinology content to help you study smarter and practice with confidence. Each episode breaks down complex topics into manageable pieces, making it ideal for endocrinology fellows and practicing endocrinologists. Whether you're preparing for boards or staying sharp in clinic, Dr. Sumbul Beg, MD brings exam ready pearls and real world relevance straight to your ears.

Be sure to visit the podcast's website and support the creator: ezendoprep.com

Author

Sumbul Beg, MD

Category

Health

Podcast website

ezendoprep.com

Latest episode

Nov 16, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Algorithm for Management of Dyslipidemia - 2025 AACE Update (Part 5) 01.12.2025

This episode reviews the evaluation of adults with severe hypertriglyceridemia, according to the 2025 AACE Algorithm. • Severe Hypertriglyceridemia: Understand impaired triglyceride clearance, chylomicron accumulation, and increased pancreatitis risk, including multifactorial causes. • Familial Chylomicronemia Syndrome: Recognize this rare, early onset disorder with persistent hypertriglyceridemia...

Algorithm for Management of Dyslipidemia - 2025 AACE Update (Part 4) 24.11.2025

This episode reviews how to evaluate and manage adults with extremely low or extremely high HDL cholesterol according to the 2025 AACE Algorithm. • Identifies secondary causes of abnormal HDL, such as renal disease, low estrogen states, hyperandrogenism, medications (fibrates, TZDs, niacin, anti epileptics), alcohol excess, estrogen therapy, or pesticide exposure. • Explains key genetic disorders...

Algorithm for Management of Dyslipidemia - 2025 AACE Update (Part 3) 17.11.2025

This episode reviews how to evaluate and manage adults with very low LDL cholesterol (<40 mg/dL) according to the 2025 AACE Algorithm. • Identifies secondary causes such as lipid lowering therapy, malnutrition, malabsorption, and chronic diseases. • Explains key genetic disorders linked to low LDL. Including MTTP, APOB, PCSK9, ANGPTL3, and SAR1B mutations. • Summarizes diagnostic clues and next...

Algorithm for Management of Dyslipidemia - 2025 AACE Update (Part 2) 10.11.2025

This episode explores the next step in the 2025 AACE Dyslipidemia Management Algorithm, focusing on adults with LDL cholesterol levels of 190 mg/dL or higher. • Discusses how to evaluate for Familial Hypercholesterolemia and rule out secondary causes. • Reviews diagnostic tools such as the Dutch Lipid Clinic Network, Simon Broome, and Welsh criteria. • Outlines a stepwise approach to assessment, g...

Algorithm for Management of Dyslipidemia - 2025 AACE Update (Part 1) 03.11.2025

This episode serves as the introduction to the series on the 2025 AACE Dyslipidemia Management Algorithm, focusing on patient centered risk assessment and lifestyle based prevention strategies. • Covers ASCVD and pancreatitis risk evaluation, lifestyle modification, and shared decision making. • Introduces ASCVD risk classification, validated risk calculators, and integrated cardiometabolic manage...

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 10 27.10.2025

In this episode, we review recommendations 73 to 84 from the 2025 American Thyroid Association guidelines on managing radioiodine refractory differentiated thyroid cancer and survivorship care. Key topics include: • Use of immunotherapy, redifferentiation therapy, and local or systemic treatments for advanced disease. • Pregnancy management, including timing of surgery, imaging considerations, and...

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 9 20.10.2025

In this episode, we review recommendations 57 to 72 from the 2025 American Thyroid Association guidelines on the management of radioiodine avid and radioiodine refractory differentiated thyroid cancer. Key topics include: • The role of RAI therapy for iodine avid bone metastases and rising thyroglobulin levels • Criteria and management strategies for RAIR disease • Monitoring and follow up of stab...

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 8 13.10.2025

In this episode, we review recommendations 51 to 56 from the 2025 American Thyroid Association guidelines on long term management of differentiated thyroid cancer. Key topics include: • The role of ongoing (dynamic) risk stratification in individualized patient management • Decision making for reoperative neck surgery and alternative local therapies such as ethanol and RFA • Indications for additi...

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 7 06.10.2025

In this episode, we review recommendations 45 to 50 from the 2025 American Thyroid Association guidelines on long term management of differentiated thyroid cancer. Key topics include: • Individualization of TSH suppression strategy • Long term considerations for TSH suppression in low and intermediate risk patients • Monitoring serum thyroglobulin and Tg antibodies as markers of disease status • F...

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 6 29.09.2025

In this episode, we break down recommendations 41 to 44 from the 2025 American Thyroid Association guidelines on differentiated thyroid cancer management. Key topics include: • Patient counseling on the small risk of second primary malignancy after RAI • Baseline labs: complete blood count and kidney function before RAI therapy • Reproductive considerations: pregnancy precautions, nursing patient...

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 5 22.09.2025

In this episode, we review key updates from the 2025 American Thyroid Association guidelines on surveillance and radioactive iodine management for adult patients with differentiated thyroid cancer. • Surveillance: Ultrasound as first line follow up; 6 to12 month intervals; FNA for nodes ≥10 mm; CT or PET for rising thyroglobulin without visible disease • Radioactive Iodine: Not routine in low risk...

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 4 15.09.2025

In this episode, we break down recommendations 21 to 30 from the 2025 American Thyroid Association guidelines on differentiated thyroid cancer management. Key topics include: • Preoperative discussion of surgical risks, including nerve and parathyroid injury • Preoperative and postoperative voice assessment and laryngeal examination • Intraoperative nerve identification and monitoring strategies •...

New Primary Aldosteronism – Endocrine Society 2025 Guidelines; Bonus Summary Episode 5 08.09.2025

This bonus summary episode distills the Endocrine Society’s 2025 guideline updates on primary aldosteronism into high yield pearls for clinical practice and board preparation. Key topics include: • Broad screening for hypertensive patients regardless of potassium status • Diagnostic evaluation with the aldosterone to renin ratio • Selective use of suppression testing and updated terminology • Adre...

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 3 08.09.2025

In this episode, we review key updates from the 2025 American Thyroid Association guidelines on surgical management for adult patients with differentiated thyroid cancer. • Surgery by tumor size: lobectomy for small, low risk tumors; total thyroidectomy for larger or advanced tumors • Thyroglossal duct carcinoma: Sistrunk procedure and thyroidectomy for higher risk cases • Central and lateral neck...

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 2 01.09.2025

In this episode, we review key updates from the 2025 ATA guidelines on surgical referral, imaging, and risk based management for adult patients with differentiated thyroid cancer. • Referral to high volume thyroid surgeons (≥25 to 50/year) for better outcomes • Comprehensive neck ultrasound; FNA for suspicious nodes ≥8 to 10 mm • Use CT or MRI if ultrasound is insufficient for invasive or bulky di...

New Primary Aldosteronism Guidelines – Endocrine Society 2025; Episode 4 01.09.2025

This episode reviews the Endocrine Society’s 2025 guideline updates on managing primary aldosteronism after initial screening. • When suppression testing is indicated or unnecessary • Cortisol cosecretion in adrenal adenomas and surgical planning • Role of adrenal vein sampling (AVS) in determining laterality, with rare exceptions • Treatment strategies for unilateral vs bilateral disease • MRA th...

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 1 25.08.2025

In this episode, we review the ATA 2025 thyroid cancer guideline updates on tumors of uncertain malignant potential and when germline genetic testing is appropriate. Topics include: • NIFTP and related tumors with strict pathologic criteria and low malignant risk • Management pearls and pitfalls of overtreatment • Indications for germline testing (PTEN, DICER1, APC, Carney complex, Werner syndrome...

New Primary Aldosteronism Guidelines – Endocrine Society 2025; Episode 3 of 4 25.08.2025

This episode reviews medications and hormonal therapies that can falsely raise the Aldosterone-to-Renin Ratio (ARR), creating false-positive results in primary aldosteronism screening. • Covers centrally acting alpha-2 agonists, beta blockers, NSAIDs, and combined estrogen-progestin therapy. • Explains mechanisms for PAC and renin changes, highlighting discordance between PRA vs DRC assays. • Revi...

New Primary Aldosteronism Guidelines – Endocrine Society 2025; Episode 2 of 4 18.08.2025

This episode reviews my key notes on medications and factors that can falsely lower the Aldosterone-to-Renin Ratio (ARR), leading to missed cases of primary aldosteronism. • Organized into strong, intermediate, and weak confounders for quick clinical reference. • Includes the most important non-medication factor to correct before testing: hypokalemia.

New Primary Aldosteronism Guidelines – Endocrine Society 2025; Episode 1 of 4 11.08.2025

• Four-part series highlighting my personal notes and key clinical insights from the newly released 2025 Endocrine Society guidelines on Primary Aldosteronism • Each episode translates complex recommendations into practical, board-focused guidance you can apply immediately • Episode 1 features two ready-to-use tools:   • Clear patient instructions to follow before lab testing   • Detailed instruct...

Lipoprotein(a): What Every Endocrinologist Should Know 04.08.2025

This high-yield episode breaks down exactly why Lp(a) is gaining attention as a critical cardiovascular risk factor. It's genetically determined, stable for life, and not modified by lifestyle. Dr. Beg reviews who needs testing, when to test, and how Lp(a) contributes to atherosclerosis, inflammation, and calcific aortic valve disease. We’ll also dive into current and emerging treatment option...

MASLD & MASH: Concise Clinical and Board Pearls 28.07.2025

Ready to master MASLD and MASH for your boards and daily practice? This episode cuts straight to the chase, delivering crucial, latest pearls on this evolving liver disease. We cover everything from new terminology and risk factors (including PCOS), to statin use, screening essentials (FIB-4, FibroScan), and the latest treatments including FDA-approved Resmetirom. Get sharp on diagnosis, managemen...

Vaccines in Patients with Diabetes 09.07.2025

Are you staying sharp for boards or brushing up on practical diabetes care? This quick episode covers the most up to date vaccine guidelines for patients with diabetes…straight from board review content. Learn how to apply CDC recommendations on Hepatitis B, Pneumococcal, Influenza, RSV, COVID-19, and Shingles. Discover smart memory tricks and practical clinical decision points to keep you board r...

Listen to the Endo in a Bite podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.